Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00492479 · ClinicalTrials.gov registry record · Phase 4
An Evaluation of Kinerase Pro+Therapy Regimen Vs. Kinerase Vs. Control for the Treatment of Skin Aging
A Phase 4 study, sponsored by Innovative Medical.
- Terminated
- Registry status
- Phase 4
- Development phase
NCT00492479 is a Phase 4 study that was terminated before completion, run by Innovative Medical.
The verdict
NCT00492479, a Phase 4 study, was terminated before completion, sponsored by Innovative Medical.
- TERMINATED
- Registry status
- Phase 4
- Development phase
Study Summary
The purpose of this study is to compare the efficacy of the Kinerase Pro+Therapy regimen versus a single Kinerase product vs. control for the treatment of the signs of skin aging.
Interventions
- DRUG Kinerase Pro+Therapy Line day repair, serum, night repair
- DRUG Kinerase Pro+Therapy Line Ultra rich day repair
- DRUG LubriDerm
Trial Details
| Field | Value |
|---|---|
| Start Date | 2007-06 |
| Est. Completion | 2007-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00492479
The ClinicalTrials.gov registry entry for NCT00492479 describes a study currently listed as terminated, categorized as Phase 4. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Innovative Medical, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Kinerase Pro+Therapy Line day repair, serum, night repair is the first listed.
NCT00492479 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00492479 about?
NCT00492479 is a clinical study titled "An Evaluation of Kinerase Pro+Therapy Regimen Vs. Kinerase Vs. Control for the Treatment of Skin Aging". The purpose of this study is to compare the efficacy of the Kinerase Pro+Therapy regimen versus a single Kinerase product vs. control for the treatment of the signs of skin aging.
What is the current status of trial NCT00492479?
This trial is currently terminated. It is a Phase 4 study. The study started on 2007-06. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00492479?
The interventions under investigation include: Kinerase Pro+Therapy Line day repair, serum, night repair (DRUG), Kinerase Pro+Therapy Line Ultra rich day repair (DRUG), LubriDerm (DRUG).
Who is sponsoring clinical trial NCT00492479?
This trial is sponsored by Innovative Medical, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.